Literature DB >> 24304078

Stem cells: intellectual property issues in regenerative medicine.

Nicholas A Zachariades1.   

Abstract

The topic of stem cells for use in regenerative medicine, especially embryonic stem cells, inspires much debate, discussion, and outrage as it slices through the very core moral values of society. These social and moral issues have, in turn, resulted in government policies that have influenced the study of stem cells in regenerative medicine.

Mesh：

Year:  2013        PMID： 24304078      PMCID： PMC3883125          DOI： 10.1089/scd.2013.0287

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN： 1547-3287            Impact factor:   3.272


  3 in total

1.  CASMI TSCC launch event, Paris, France, July 2013: an assessment of the key barriers to the commercialization and clinical adoption of pluripotent stem cell therapies.

Authors:  Anna French; Kim Bure; David A Brindley
Journal:  Rejuvenation Res       Date:  2014-02       Impact factor: 4.663

Review 2.  Therapeutic Use of Mesenchymal Stromal Cells: The Need for Inclusive Characterization Guidelines to Accommodate All Tissue Sources and Species.

Authors:  Adrienne Wright; Marne L Arthaud-Day; Mark L Weiss
Journal:  Front Cell Dev Biol       Date:  2021-02-16

3.  Interfacing of Science, Medicine and Law: The Stem Cell Patent Controversy in the United States and the European Union.

Authors:  Sonya Davey; Neil Davey; Qian Gu; Na Xu; Rajet Vatsa; Samir Devalaraja; Paul Harris; Sreenivas Gannavaram; Raj Dave; Ananda Chakrabarty
Journal:  Front Cell Dev Biol       Date:  2015-11-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.